Table of Contents

1 Arformoterol Market Overview

• 1.1 Product Overview and Scope of Arformoterol
• 1.2 Classification of Arformoterol by Types
  • 1.2.1 Global Arformoterol Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Arformoterol Revenue Market Share by Types in 2018
  • 1.2.3 Brovana
  • 1.2.4 Generic
• 1.3 Global Arformoterol Market by Application
  • 1.3.1 Global Arformoterol Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital
  • 1.3.3 Drug store
• 1.4 Global Arformoterol Market by Regions
  • 1.4.1 Global Arformoterol Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Arformoterol Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Arformoterol Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Arformoterol Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Arformoterol Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Arformoterol Status and Prospect (2014-2024)
• 1.5 Global Market Size of Arformoterol (2014-2024)

2 Manufacturers Profiles

• 2.1 Sunovion Pharmaceuticals
  • 2.1.1 Business Overview
  • 2.1.2 Arformoterol Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Sunovion Pharmaceuticals Arformoterol Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Cipla
  • 2.2.1 Business Overview
  • 2.2.2 Arformoterol Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Cipla Arformoterol Revenue, Gross Margin and Market Share (2017-2018)

3 Global Arformoterol Market Competition, by Players

• 3.1 Global Arformoterol Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Arformoterol Players Market Share
  • 3.2.2 Top 10 Arformoterol Players Market Share
• 3.3 Market Competition Trend

4 Global Arformoterol Market Size by Regions

• 4.1 Global Arformoterol Revenue and Market Share by Regions
• 4.2 North America Arformoterol Revenue and Growth Rate (2014-2019)
• 4.3 Europe Arformoterol Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Arformoterol Revenue and Growth Rate (2014-2019)
• 4.5 South America Arformoterol Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Arformoterol Revenue and Growth Rate (2014-2019)

5 North America Arformoterol Revenue by Countries

• 5.1 North America Arformoterol Revenue by Countries (2014-2019)
• 5.2 USA Arformoterol Revenue and Growth Rate (2014-2019)
• 5.3 Canada Arformoterol Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Arformoterol Revenue and Growth Rate (2014-2019)

6 Europe Arformoterol Revenue by Countries

• 6.1 Europe Arformoterol Revenue by Countries (2014-2019)
• 6.2 Germany Arformoterol Revenue and Growth Rate (2014-2019)
• 6.3 UK Arformoterol Revenue and Growth Rate (2014-2019)
• 6.4 France Arformoterol Revenue and Growth Rate (2014-2019)
• 6.5 Russia Arformoterol Revenue and Growth Rate (2014-2019)
• 6.6 Italy Arformoterol Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Arformoterol Revenue by Countries

• 7.1 Asia-Pacific Arformoterol Revenue by Countries (2014-2019)
• 7.2 China Arformoterol Revenue and Growth Rate (2014-2019)
• 7.3 Japan Arformoterol Revenue and Growth Rate (2014-2019)
• 7.4 Korea Arformoterol Revenue and Growth Rate (2014-2019)
• 7.5 India Arformoterol Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Arformoterol Revenue and Growth Rate (2014-2019)

8 South America Arformoterol Revenue by Countries

• 8.1 South America Arformoterol Revenue by Countries (2014-2019)
• 8.2 Brazil Arformoterol Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Arformoterol Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Arformoterol Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Arformoterol by Countries

• 9.1 Middle East and Africa Arformoterol Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Arformoterol Revenue and Growth Rate (2014-2019)
• 9.3 UAE Arformoterol Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Arformoterol Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Arformoterol Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Arformoterol Revenue and Growth Rate (2014-2019)

10 Global Arformoterol Market Segment by Type

• 10.1 Global Arformoterol Revenue and Market Share by Type (2014-2019)
• 10.2 Global Arformoterol Market Forecast by Type (2019-2024)
• 10.3 Brovana Revenue Growth Rate (2014-2024)
• 10.4 Generic Revenue Growth Rate (2014-2024)

11 Global Arformoterol Market Segment by Application

• 11.1 Global Arformoterol Revenue Market Share by Application (2014-2019)
• 11.2 Arformoterol Market Forecast by Application (2019-2024)
• 11.3 Hospital Revenue Growth (2014-2019)
• 11.4 Drug store Revenue Growth (2014-2019)

12 Global Arformoterol Market Size Forecast (2019-2024)

• 12.1 Global Arformoterol Market Size Forecast (2019-2024)
• 12.2 Global Arformoterol Market Forecast by Regions (2019-2024)
• 12.3 North America Arformoterol Revenue Market Forecast (2019-2024)
• 12.4 Europe Arformoterol Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Arformoterol Revenue Market Forecast (2019-2024)
• 12.6 South America Arformoterol Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Arformoterol Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology

Arformoterol is a long-acting β2 adrenoreceptor agonist (LABA) indicated for the treatment of chronic obstructive pulmonary disease (COPD). It is sold by Sunovion, under the trade name Brovana, as a solution of arformoterol tartrate to be administered twice daily (morning and evening) by nebulization.

Scope of the Report:
The global Arformoterol market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Arformoterol.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Arformoterol market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Arformoterol market by product type and applications/end industries.

Market Segment by Companies, this report covers
Sunovion Pharmaceuticals
Cipla

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Brovana
Generic

Market Segment by Applications, can be divided into
Hospital
Drug store